H. Salomón

发表

Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection Study.

M. Wainberg, B. Brenner, H. Salomón, 2000, International journal of antimicrobial agents.

Characterization of GPI2A, a Potent Inhibitor of HIV-1 Gene Expression and Viral Replication

M. Wainberg, H. Salomón, Jim A. Wright, 1997 .

Cytotoxic and DNA interaction activities of extracts from medicinal plants used in Argentina.

H. Salomón, G. Ciccia, E. Mongelli, 2000, Journal of ethnopharmacology.

Bioinformatic analysis of post-transmission viral readaptation in Argentine patients with acute HIV-1 infection.

G. Damilano, H. Salomón, P. Cahn, 2020, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Generation of multiple drug resistance by sequential in vitro passage of the human immunodeficiency virus type 1

M. Wainberg, H. Salomón, Q. Gao, 2005, Archives of Virology.

Origin of Human Immunodeficiency Virus Type 1 Quasispecies Emerging after Antiretroviral Treatment Interruption in Patients with Therapeutic Failure

M. Markowitz, H. Salomón, P. Cahn, 2002, Journal of Virology.

3′-AZIDO-3′-DEOXY-5′-O-ISONICOTINOYLTHYMIDINE, A NEW PRODRUG OF ZIDOVUDINE. SYNTHESIS, SOLID STATE CHARACTERIZATION AND ANTI HIV-1 ACTIVITY

H. Salomón, M. C. Brinón, M. Motura, 2002, Nucleosides, nucleotides & nucleic acids.

Selection of Resistance-Conferring Mutations in HIV-1 by the Nucleoside Reverse Transcriptase Inhibitors (+/-)dOTC and (+/-)dOTFC

M. Wainberg, H. Salomón, Maureen Oliveira, 2000, Antiviral chemistry & chemotherapy.

Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants Resistant to the (+) and (−) Enantiomers of 2′-Deoxy-3′-Oxa-4′-Thio-5-Fluorocytidine

M. Wainberg, H. Salomón, T. Mansour, 2000, Antimicrobial Agents and Chemotherapy.

Selection and Characterization of HIV-1 Variants Resistant to the (+) and (-) Enantiomers of 2′-Deoxy-3′-Oxa-4′-Thiocytidine (Dotc)

M. Wainberg, H. Salomón, J. Bédard, 1998, Antiviral therapy.

Diminished HIV-1 Sensitivity to Stavudine in Patients on Prolonged Therapy Occurs Only at Low Levels and Cannot be Attributed to Any Single Amino Acid Substitution in Reverse Transcriptase

J. Montaner, M. Wainberg, H. Salomón, 1998, Antiviral therapy.

Resistance Profile of a Novel 2′, 3′ - Dideoxynucleoside Analog with Activity Against HIV-1

M. Wainberg, H. Salomón, T. Mansour, 1997 .

Mutations at codon 184 in simian immunodeficiency virus reverse transcriptase confer resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine

M. Wainberg, H. Salomón, M. Slater, 1997, Antimicrobial agents and chemotherapy.

The nucleoside analog-resistant E89G mutant of human immunodeficiency virus type 1 reverse transcriptase displays a broader cross-resistance that extends to nonnucleoside inhibitors

M. Wainberg, Y. Kew, H. Salomón, 1996, Antimicrobial agents and chemotherapy.

Host Cell Dependence of Human Immunodeficiency Virus Type-1 Drug Resistance Profiles and Tissue Culture Selection Patterns

M. Wainberg, H. Salomón, Q. Gao, 1995 .

HCV RNA decline in the first 24 h exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirin.

H. Salomón, P. Cahn, A. Martínez, 2011, Antiviral research.

Randomised Study of the Possible Adjuvant Effect of BCG Vaccine on the Immunogenicity of Diphtheria-Tetanus-Acellular Pertussis Vaccine in Senegalese Infants

H. Salomón, J. Trape, S. Pinchinat, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Early Skewed Distribution of Total and HIV-Specific CD8+ T-Cell Memory Phenotypes during Primary HIV Infection Is Related to Reduced Antiviral Activity and Faster Disease Progression

H. Salomón, P. Cahn, O. Sued, 2014, PloS one.

Etiologic and clinical evaluation of acute lower respiratory tract infections in young Argentinian children: an overview.

H. Salomón, M. Catalano, M. Weissenbacher, 1990, Reviews of infectious diseases.

Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin‐12

H. Salomón, J. Sabatté, A. Ceballos, 2007, Immunology.

HLA class II involvement in HIV-associated Toxoplasmic encephalitis development.

H. Salomón, J. Quarleri, A. Rubio, 2005, Clinical immunology.

Uncommon hepatitis B virus and/or hepatitis C virus occult infection in HIV-positive patients with abnormal level of hepatic enzyme.

H. Salomón, M. B. Bouzas, P. Cahn, 2008, Journal of acquired immune deficiency syndromes.

HIV–TB coinfection impairs CD8+ T‐cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses

H. Salomón, P. Cahn, O. Sued, 2015, European journal of immunology.

Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis

D. Harris, H. Salomón, L. Soto-Ramírez, 2007, AIDS.

High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern.

H. Salomón, M. Biglione, L. Astarloa, 2005, AIDS research and human retroviruses.

Dynamics of Adrenal Steroids Are Related to Variations in Th1 and Treg Populations during Mycobacterium tuberculosis Infection in HIV Positive Persons

H. Salomón, P. Cahn, O. Sued, 2012, PloS one.

H. Salomón, E. Arts, D. Tebit, 2014, PloS one.

Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4+ T-cell Count?

Pedro A. Pury, H. Salomón, O. Sued, 2018, Viruses.

Research priorities for HIV/M. tuberculosis co-infection

B. Berkhout, J. Nachega, G. Bocharov, 2011 .

7-oxo-DHEA enhances impaired M. tuberculosis-specific T cell responses during HIV-TB coinfection

H. Salomón, O. Sued, M. Corti, 2020, Journal of Biomedical Science.

Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8+ T-cell responses and disease progression

H. Salomón, P. Cahn, O. Sued, 2015, Scientific Reports.

Expansion of CD25-Negative Forkhead Box P3-Positive T Cells during HIV and Mycobacterium tuberculosis Infection

H. Salomón, O. Sued, N. Laufer, 2017, Front. Immunol..

Early Gag Immunodominance of the HIV-Speciﬁc T-Cell Response during Acute/Early Infection Is Associated with Higher CD8 (cid:1) T-Cell Antiviral Activity and Correlates with Preservation of the CD4 (cid:1) T-Cell Compartment

H. Salomón, P. Cahn, O. Sued, 2013 .

HLA-Driven Convergence of HIV-1 Viral Subtypes B and F Toward the Adaptation to Immune Responses in Human Populations

H. Salomón, P. Cahn, L. Jones, 2008, PloS one.

Clinical correlates of in vitro HIV‐1 resistance to zidovudine. Results of the Multicentre Canadian AZT Trial

J. Singer, J. Montaner, M. Wainberg, 1993, AIDS.

HIV-mediated up-regulation of invariant chain (CD74) correlates with generalized immune activation in HIV+ subjects.

H. Salomón, P. Benaroch, M. Schindler, 2012, Virus research.

Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein

H. Salomón, Y. Ghiglione, G. Turk, 2010, Virology Journal.

ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosis

H. Salomón, P. Cahn, O. Sued, 2012, Journal of the International AIDS Society.

New acellular pertussis-containing paediatric combined vaccines.

H. Salomón, S. Wood, A. Hoffenbach, 1999, Vaccine.

Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa

H. Salomón, P. Cahn, V. Fink, 2019, Scientific Reports.

Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro.

M. Wainberg, H. Salomón, T. Mansour, 1995, Journal of medicinal chemistry.

Resistance Profile of Human Immunodeficiency Virus 1 (HIV-1) Quasispecies in Patients Under Treatment Failure Using Single Molecule, Real-Time (SMRT) Sequencing.

H. Salomón, E. Hunter, D. Dilernia, 2020, AIDS.

Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome.

M. Wainberg, H. Salomón, J. Wright, 1995, Gene.

Antiretroviral activity of fucoidans extracted from the brown seaweed Adenocystis utricularis

H. Salomón, C. A. Stortz, N. Ponce, 2009, Phytotherapy research : PTR.

Analysis of Suppressor and Non-Suppressor FOXP3+ T Cells in HIV-1-Infected Patients

H. Salomón, J. Sabatté, J. Geffner, 2012, PloS one.

Identification of mutations

H. Salomón, Z. Gu, Gao, 2016 .

Inhibitory Effect of Medicinal Herbs against RNA and DNA Viruses

H. Salomón, R. Campos, L. Cavallaro, 2004, Antiviral chemistry & chemotherapy.

A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedules.

B. Yvonnet, H. Salomón, J. Excler, 1995, The Journal of infectious diseases.

Acute lower respiratory infection in Argentinian children: A 40 month clinical and epidemiological study

H. Salomón, M. Weissenbacher, M. Ávila, 1993, Pediatric pulmonology.

Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups.

J. Carr, H. Salomón, K. Russell, 2002 .

Isolation and identification of viral agents in Argentinian children with acute lower respiratory tract infection.

H. Salomón, M. Weissenbacher, M. Ávila, 1990, Reviews of infectious diseases.

Single Nef proteins from HIV type 1 subtypes C and F fail to upregulate invariant chain cell surface expression but are active for other functions.

H. Salomón, P. Benaroch, M. Schindler, 2009, AIDS research and human retroviruses.

Development of HIV‐1 resistance to (−)2′‐deoxy‐3′‐thiacytidine in patients with AIDS or advanced AIDS‐related complex

J. Montaner, M. Wainberg, H. Salomón, 1995, AIDS.

A possible case of myelopathy/tropical spastic paraparesis in an Argentinian woman with human T lymphocyte virus type II.

H. Salomón, M. Berría, M. Biglione, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Resistance profiles of (+)2'-deoxy-3'-oxa-4'-thiocytidine and (-)2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine.

M. Wainberg, H. Salomón, N. Richard, 1999, Nucleosides & nucleotides.

A cluster of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Jujuy, Argentina.

H. Salomón, M. Berría, M. Biglione, 2003, Journal of acquired immune deficiency syndromes.

Enhanced Fidelity of 3TC-Selected Mutant HIV-1 Reverse Transcriptase

M. Wainberg, H. Salomón, W. C. Drosopoulos, 1996, Science.

Higher Rate of Toxicity With No Increased Efficacy When Hydroxyurea Is Added to a Regimen of Stavudine Plus Didanosine and Nevirapine in Primary HIV Infection

Julio S. G. Montaner, H. Salomón, P. Cahn, 2002, Journal of acquired immune deficiency syndromes.

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters

Héctor Pérez, Carina Cesar, H. Salomón, 2011, Journal of the International AIDS Society.

Comparison of three techniques for detection of respiratory viruses in nasopharyngeal aspirates from children with lower acute respiratory infections

H. Salomón, M. Weissenbacher, M. Ávila, 1989, Journal of medical virology.

Interaction Between Macrophage Migration Inhibitory Factor and CD74 in Human Immunodeficiency Virus Type I Infected Primary Monocyte-Derived Macrophages Triggers the Production of Proinflammatory Mediators and Enhances Infection of Unactivated CD4+ T Cells

L. Leng, R. Bucala, H. Salomón, 2018, Front. Immunol..

Development and significance of nucleoside drug resistance in infection caused by the human immunodeficiency virus type 1.

M. Wainberg, H. Salomón, M. Smith, 1994, Clinical and investigative medicine. Medecine clinique et experimentale.

Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine

M A Wainberg, M. Wainberg, H. Salomón, 1994, Antimicrobial Agents and Chemotherapy.

No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30 days course of nitazoxanide monotherapy.

H. Salomón, P. Cahn, A. Krolewiecki, 2011, Antiviral research.

Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity

H. Salomón, P. Cahn, O. Sued, 2015, Journal of Virology.

Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: a 3-yr prospective study.

H. Salomón, R. Campos, J. Quarleri, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B.

H. Salomón, M. B. Bouzas, P. Cahn, 2007, AIDS research and human retroviruses.

Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina.

J. Carr, H. Salomón, K. Russell, 2004, The American journal of tropical medicine and hygiene.

K65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenine

M. Wainberg, A. Foli, H. Salomón, 1995, Antimicrobial Agents and Chemotherapy.

In vitro Selection and Characterization of HIV-1 with Reduced Susceptibility to PMPA

M. Wainberg, H. Salomón, J. Cherrington, 1998, Antiviral therapy.

Structure-Activity Relationships Among a New Class of Antiviral Heterosubstituted 2′,3′-Dideoxynucleoside Analogues

M. Wainberg, H. Salomón, J. Gillard, 1995 .

Mother-to-Child Transmission of Hepatitis C Virus (HCV) Among HIV/HCV-Coinfected Women.

S. Stoszek, H. Salomón, J. Read, 2013, Journal of the Pediatric Infectious Diseases Society.

Hepatitis B virus, hepatitis C virus and HIV coinfection among people living with HIV/AIDS in Buenos Aires, Argentina.

H. Salomón, M. B. Bouzas, P. Cahn, 2010, Sexually Transmitted Diseases.

Antiretroviral activity and cytotoxicity of novel zidovudine (AZT) derivatives and the relation to their chemical structure.

H. Salomón, M. C. Brinón, S. Pampuro, 2002, International journal of antimicrobial agents.

Antiviral activity and resistance profile of phosphazid--a novel prodrug of AZT.

M. Wainberg, H. Salomón, C. Tsoukas, 1999, Nucleosides & nucleotides.

Estimation of HIV-Testing Rates to Maximize Early Diagnosis-Derived Benefits at the Individual and Population Level

H. Salomón, P. Cahn, S. Friedman, 2013, PloS one.

Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: plasma versus PBMCs.

D. Harris, H. Salomón, L. Soto-Ramírez, 2008, AIDS research and human retroviruses.

Low Rate of Emergence of Nevirapine and Lamivudine Resistance after Post-Partum Interruption of a Triple-Drug Regimen

H. Salomón, P. Cahn, M. Rolón, 2008, Antiviral therapy.

Structure-Activity Relationships Among a New Class of Antiviral Heterosubstituted 2′,3′-Dideoxynucleoside Analogues.

M. Wainberg, H. Salomón, J. Gillard, 2010 .

Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy

S. Lewin, H. Salomón, S. Bakkour, 2020, Open forum infectious diseases.

High frequency of primary mutations associated with antiretroviral drug resistance in recently diagnosed HIV-infected children

H. Salomón, J. Quarleri, G. Barboni, 2007, Antiviral therapy.

Attenuated infectivity of HIV type 1 from epithelial cells pretreated with a tight-binding nonnucleoside reverse transcriptase inhibitor.

M. Wainberg, H. Salomón, M. Parniak, 2002, AIDS research and human retroviruses.

Incidence of HIV type 1 infection, antiretroviral drug resistance, and molecular characterization in newly diagnosed individuals in Argentina: A Global Fund Project.

H. Salomón, D. Rossi, M. Pando, 2011, AIDS research and human retroviruses.

HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.

H. Salomón, M. B. Bouzas, P. Cahn, 2007, Acta gastroenterologica Latinoamericana.

Human Seminal Plasma Abrogates the Capture and Transmission of Human Immunodeficiency Virus Type 1 to CD4+ T Cells Mediated by DC-SIGN

H. Salomón, S. Amigorena, J. Sabatté, 2007, Journal of Virology.

Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina.

M. Thomson, L. Pérez-Alvárez, H. Salomón, 2000, AIDS.

Drug-resistance surveillance among newly HIV-1 diagnosed individuals in Buenos Aires, Argentina

H. Salomón, A. Gomez, C. Bautista, 2007, AIDS.

Computational comparison of availability in CTL/gag epitopes among patients with acute and chronic HIV-1 infection.

G. Damilano, H. Salomón, P. Cahn, 2018, Vaccine.

HIV type 1 BF recombinant strains exhibit different pol gene mosaic patterns: descriptive analysis from 284 patients under treatment failure.

J. Montaner, H. Salomón, R. Harrigan, 2004, AIDS research and human retroviruses.

Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America

J. Carr, D. Birx, F. McCutchan, 2001, AIDS.

Analysis of HIV type 1 BF recombinant sequences from South America dates the origin of CRF12_BF to a recombination event in the 1970s.

G. Damilano, H. Salomón, L. Jones, 2010, AIDS research and human retroviruses.

Characterization of DNA and MVA vectors expressing Nef from HIV-1 CRF12_BF revealed high immune specificity with low cross-reactivity against subtype B.

H. Salomón, M. Esteban, A. M. Rodríguez, 2009, Virus research.

Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina

H. Salomón, J. Quarleri, G. Barboni, 2009, Antiviral Therapy.

In-depth analysis of the origins of HIV type 1 subtype C in South America.

H. Salomón, L. Jones, J. Manrique, 2009, AIDS research and human retroviruses.

In vitro dynamics of HIV-1 BF intersubtype recombinants genomic regions involved in the regulation of gene expression

H. Salomón, G. Turk, C. R. Rodrigues, 2009, Virology Journal.

Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina

H. Salomón, J. Quarleri, G. Barboni, 2009, Antiviral therapy.

Magnitude, Breadth, and Functional Profile of T-Cell Responses during Human Immunodeficiency Virus Primary Infection with B and BF Viral Variants

H. Salomón, P. Cahn, J. Cox, 2008, Journal of Virology.

HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina.

H. Salomón, A. Gomez, M. Losso, 2007, AIDS research and human retroviruses.

Examination of real-time PCR for HIV-1 RNA and DNA quantitation in patients infected with HIV-1 BF intersubtype recombinant variants.

H. Salomón, C. Rouzioux, G. Turk, 2007, Journal of virological methods.

Analysis of HIV type 1 diversity in pregnant women from four Latin American and Caribbean countries.

D. Harris, H. Salomón, L. Soto-Ramírez, 2006, AIDS research and human retroviruses.

Higher transactivation activity associated with LTR and Tat elements from HIV-1 BF intersubtype recombinant variants

H. Salomón, A. Rubio, G. Turk, 2006, Retrovirology.

Drug resistance testing provides evidence of the globalization of HIV type 1: a new circulating recombinant form.

J. Carr, H. Salomón, J. Quarleri, 2004, AIDS research and human retroviruses.

Differences in frequencies of drug resistance-associated mutations in the HIV-1 pol gene of B subtype and BF intersubtype recombinant samples.

H. Salomón, J. Quarleri, A. Rubio, 2004, Journal of acquired immune deficiency syndromes.

Mother-to-child transmission of drug-resistant HIV.

H. Salomón, M. Ávila, G. Kijak, 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Intersubtype BF Recombinants of HIV-1 in a Population of Injecting Drug Users in Argentina

H. Sheppard, H. Salomón, D. Rossi, 2004, Journal of acquired immune deficiency syndromes.

HIV type 1 genetic diversity is a major obstacle for antiretroviral drug resistance hybridization-based assays.

H. Salomón, J. Quarleri, G. Kijak, 2001, AIDS research and human retroviruses.

A highly prevalent polymorphism at codon 72 of HIV-1 reverse transcriptase in Argentina prevents hybridization reaction at codon 74 in the LiPA genotyping test.

H. Salomón, G. Kijak, M. Carobene, 2001, Journal of virological methods.

PD-1 Expression in HIV-Specific CD8+ T cells Before Antiretroviral Therapy Is Associated With HIV Persistence

S. Lewin, H. Salomón, O. Sued, 2019, Journal of acquired immune deficiency syndromes.

Host Genetic Factors Associated with Symptomatic Primary HIV Infection and Disease Progression among Argentinean Seroconverters

H. Salomón, P. Cahn, O. Sued, 2014, PloS one.

T-Cell Antiviral Activity and + Higher CD8 Acute/Early Infection Is Associated with HIV-Specific T-Cell Response during Early Gag Immunodominance of the

H. Salomón, P. Cahn, O. Sued, 2014 .

Early Gag Immunodominance of the HIV-Specific T-Cell Response during Acute/Early Infection Is Associated with Higher CD8+ T-Cell Antiviral Activity and Correlates with Preservation of the CD4+ T-Cell Compartment

H. Salomón, P. Cahn, O. Sued, 2013, Journal of Virology.

Phenotype, Polyfunctionality, and Antiviral Activity of in vitro Stimulated CD8+ T-Cells From HIV+ Subjects Who Initiated cART at Different Time-Points After Acute Infection

H. Salomón, O. Sued, M. Gherardi, 2018, Front. Immunol..

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use

M A Wainberg, M. Wainberg, B. Brenner, 2000, AIDS.

A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3.

R. Davey, H. Lane, H. Salomón, 2000, The Journal of infectious diseases.

HIV-1 viral load: comparative evaluation of three commercially available assays in Argentina.

H. Salomón, V. Hodara, O. Libonatti, 1998, Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia.

Resistance profile of HIV-1 quasispecies in patients under treatment failure using single molecule, real-time sequencing.

H. Salomón, E. Hunter, D. Dilernia, 2020, AIDS.

Prevalence of Rilpivirine Resistance in People Starting Antiretroviral Treatment in Argentina

H. Salomón, M. B. Bouzas, S. Giuliano, 2017, Antiviral therapy.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina

H. Salomón, M. B. Bouzas, I. Zapiola, 2013, Journal of the International AIDS Society.

HIV-1 infection downregulates nuclear telomerase activity on lymphoblastoic cells without affecting the enzymatic components at the transcriptional level.

H. Salomón, J. Quarleri, R. Reynoso, 2006, AIDS research and human retroviruses.

Human immunodeficiency virus-1 BF intersubtype recombinant viral protein U second α helix plays an important role in viral release and BST-2 degradation.

H. Salomón, G. Duette, Cristian De Candia, 2013, The Journal of general virology.

Analysis of Sequence Configurations of the PKR-Interacting HCV Proteins from Plasma and PBMC as Predictors of Response to Interferon-Alpha and Ribavirin Therapy in HIV-Coinfected Patients

H. Salomón, R. Arduino, J. Quarleri, 2008, Intervirology.

HIV Epidemiology in Latin America

H. Salomón, M. Pando, 2017 .

Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates

G. Damilano, H. Salomón, O. Sued, 2017, EBioMedicine.

Modulation of the phenotype and function of Mycobacterium tuberculosis-stimulated dendritic cells by adrenal steroids.

H. Salomón, O. Bottasso, G. Suárez, 2013, International immunology.

[Prevalence of HTLV-I/II infection among blood donors in Santa Fe Province, Argentina].

H. Salomón, M. Biglione, L. Astarloa, 2004, Medicina.

Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa

H. Salomón, P. Cahn, V. Fink, 2019, Scientific Reports.

Resistance Profiles to Antiretroviral Drugs in HIV-1 Drug-Naive Patients in Argentina

M. Wainberg, H. Salomón, P. Cahn, 2001, Antiviral therapy.

Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine

H. Salomón, P. Jungers, A. Couroucé, 1994, The Lancet.

High human immunodeficiency virus type 1 seroprevalence in men who have sex with men in Buenos Aires, Argentina: risk factors for infection.

H. Salomón, K. Russell, Jose L. Sanchez, 2003, International journal of epidemiology.

Improved strategies for HIV diagnosis among men who have sex with men (MSM) in Buenos Aires, Argentina, a population with a high prevalence and incidence of HIV infection

H. Salomón, R. Marone, M. Gómez-Carrillo, 2012, HIV medicine.

Comparison of cord blood and peripheral blood mononuclear cells as targets for viral isolation and drug sensitivity studies involving human immunodeficiency virus type 1

M. Wainberg, H. Salomón, M. Gelfand, 1994, Journal of clinical microbiology.

Anti‐human immunodeficiency virus type 1 (HIV‐1) activity of Achyrocline flaccida Wein DC and Gamochaeta simplicicaulis aqueous extracts

H. Salomón, R. Campos, L. Cavallaro, 1997 .

Discrepant results in the interpretation of HIV‐1 drug‐resistance genotypic data among widely used algorithms

J. Montaner, H. Salomón, P. Cahn, 2003, HIV medicine.

Two HIV‐1 Epidemics in Argentina: Different Genetic Subtypes Associated With Different Risk Groups

J. Carr, H. Salomón, K. Russell, 2002, Journal of acquired immune deficiency syndromes.

Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART

H. Salomón, P. Cahn, O. Sued, 2021, Pathogens & immunity.

Didanosine Compared with Continued Zidovudine Therapy for HIV-Infected Patients with 200 to 500 CD4 Cells/mm3: A Double-Blind, Randomized, Controlled Trial

M. Wainberg, M. Schechter, H. Salomón, 1995, Annals of Internal Medicine.

Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014–15

H. Salomón, M. B. Bouzas, I. Zapiola, 2017, The Journal of antimicrobial chemotherapy.

7-oxo-DHEA enhances impaired M. tuberculosis-specific T cell responses during HIV-TB coinfection

H. Salomón, O. Sued, M. Corti, 2020, Journal of Biomedical Science.

[The importance of early diagnosis for the survival of HIV positive patients].

H. Salomón, P. Cahn, A. Krolewiecki, 2010, Medicina.

Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender, and age issues.

H. Salomón, L. Jones, J. Manrique, 2012, AIDS research and human retroviruses.

No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30 days course of nitazoxanide monotherapy.

H. Salomón, P. Cahn, A. Krolewiecki, 2011, Antiviral research.

First report of HIV-2 infection in Argentina.

M. Wainberg, H. Salomón, E. Rud, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Acute HIV seroconversion presenting with active tuberculosis and associated with high levels of T-regulatory cells.

H. Salomón, P. Cahn, O. Sued, 2011, Viral immunology.

Resistance to (-)-2',3'-dideoxy-3'-thiacytidine (3TC) in HIV-1 isolated from paediatric patients.

M. Wainberg, H. Salomón, B. Spira, 1996, Antiviral therapy.

Modulation of the phenotype and function of Mycobacterium tuberculosis-stimulated dendritic cells by adrenal steroids.

H. Salomón, O. Bottasso, G. Suárez, 2013, International immunology.

In vitro dynamics of HIV-1 BF intersubtype recombinants genomic regions involved in the regulation of gene expression

H. Salomón, G. Turk, C. R. Rodrigues, 2009, Virology Journal.